207_Combined course Presentations
SWOG 0023: Decreased OS for patients receiving maintenance Gefitinib
Decreased OS was a result of tumor progression and not Gefitinib toxicity
Kelly K, et al. JCO 2008;26
Made with FlippingBook
SWOG 0023: Decreased OS for patients receiving maintenance Gefitinib
Decreased OS was a result of tumor progression and not Gefitinib toxicity
Kelly K, et al. JCO 2008;26
Made with FlippingBook